戻る Agenda
Session 3 : How will the Use of AI/ML, or More Generally Use of DX Change CDM Operation? Or the Change Has Already Started?
Session Chair(s)
Yuu Jincho, JD, MSc
Clinical Operation & Platforms /Data Management & Strategy, GlaxoSmithKline K.K., Japan
Noriyuki Shibayama
Group Manager, Data Managemnet, Janssen Pharmaceutical K.K., Japan
Speaker(s)
Test Automation and AI solution for Clinical Data System Development
Yuting Ji
Senior Program Manager of Clinical Database Testing, MSD, China
Creating Value of the Data, by the Data, for the Data: The Synergy of CDM and Technology
Prasanna Rao
Chief Products and Innovation Officer, Saama, United States
Considerations for Intelligent Automation Value & its Validation in Pharmacovigilance
Yusuke Miyama
, Pfizer Japan Inc., Japan